KJIM :: Korean Journal of Internal Medicine

Canagliflozin attenuates kidney injury, gut-derived toxins, and gut microbiota imbalance in high-salt diet-fed Dahl salt-sensitive rats

Lili He, Qingjuan Zuo, Sai Ma, Guorui Zhang, Zhongli Wang, Tingting Zhang, Jianlong Zhai, Yifang Guo

The Kidney–Gut Axis as a Novel Target for Nutritional Intervention to Counteract Chronic Kidney Disease Progression

Sandra Cabała, Małgorzata Ożgo, Agnieszka Herosimczyk

Metabolome evidence of CKDu risks after chronic exposure to simulated Sri Lanka drinking water in zebrafish

Pan-Pan Jia, Yan Li, Lan-Chen Zhang, Ming-Fei Wu, Tian-Yun Li, De-Sheng Pei

Ecotoxicology and Environmental Safety.2024; 273: 116149. CrossRef

Kangxianling formula attenuates renal fibrosis by regulating gut microbiota

Pengyu Tao, Haiyan Liu, Guangjian Hou, Jianrao Lu, Yukun Xu

European Journal of Medical Research.2024;[Epub] CrossRef

Microbiota analysis in individuals with type two diabetes mellitus and end‑stage renal disease: A pilot study

Maria Trandafir, Gratiela Pircalabioru, Octavian Savu

Experimental and Therapeutic Medicine.2024;[Epub] CrossRef

Revitalizing the Gut Microbiome in Chronic Kidney Disease: A Comprehensive Exploration of the Therapeutic Potential of Physical Activity

Marieke Vandecruys, Stefan De Smet, Jasmine De Beir, Marie Renier, Sofie Leunis, Hanne Van Criekinge, Griet Glorieux, Jeroen Raes, Karsten Vanden Wyngaert, Evi Nagler, Patrick Calders, Diethard Monbaliu, Véronique Cornelissen, Pieter Evenepoel, Amaryllis

Evaluation of probiotic efficacy of indigenous yeast strain, Saccharomyces cerevisiae Y-89 isolated from a traditional fermented beverage of West Bengal, India having protective effect against DSS-induced colitis in experimental mice

Exploring the potential link between gut microbiota and chronic kidney disease in causality: A 2-sample Mendelian randomization study

Wen Wen Zhang, Jin Lin Huo, Mei Di Xiao, Ya Jie Xu, Jin Zhou

Pathogenetic relationship of microbiome and metabolic disorders on the background of hypertension and gout: Potential targets of pharmacotherapy

S. D. Sinyushkina, A. V. Gorinova, A. S. Belousova, Yu. A. Sorokina, O. V. Zanozina

Meditsinskiy sovet = Medical Council.2024; (16): 292. CrossRef

Slight Changes in the Gut Microbiome in Early-stage Chronic Kidney Disease of Unknown Etiology

Ditsayathan Banjong, Thatsanapong Pongking, Na T. D. Tran, Somchai Pinlaor, Rungtiwa Dangtakot, Kitti Intuyod, Sirirat Anutrakulchai, Ubon Cha’on, Porntip Pinlaor

Microbes and Environments.2023; 38(3): n/a. CrossRef

Features of assessing the intestinal barrier permeability in chronic kidney disease

M. O. Pyatchenkov, A. A. Vlasov, E. V. Sherbakov, A. N. Belskykh, E. V. Kryukov, A. G. Markov

Experimental and Clinical Gastroenterology.2023; (11): 46. CrossRef

Sodium Butyrate as Key Regulator of Mitochondrial Function and Barrier Integrity of Human Glomerular Endothelial Cells

Maria Novella Nicese, Roel Bijkerk, Anton Jan Van Zonneveld, Bernard M. Van den Berg, Joris I. Rotmans

International Journal of Molecular Sciences.2023; 24(17): 13090. CrossRef

Relationship between Intestinal Microbiota and Complications of Type 2 Diabetes

Advances in Clinical Medicine.2023; 13(02): 1410. CrossRef

Causal effects of gut microbiota on the risk of chronic kidney disease: a Mendelian randomization study

Mingli Luo, Jiahao Cai, Shulu Luo, Xiaosi Hong, Lingxin Xu, Honghong Lin, Xiong Chen, Wen Fu

Frontiers in Cellular and Infection Microbiology.2023;[Epub] CrossRef

Regulation of gut microbiota: a novel pretreatment for complications in patients who have undergone kidney transplantation

Jiajia Ye, Junxia Yao, Fangfang He, Jing Sun, Zheng Zhao, Yumei Wang

Frontiers in Cellular and Infection Microbiology.2023;[Epub] CrossRef

Gut Microbiome in Patients after Heart Transplantation—Current State of Knowledge

Katarzyna Olek, Agnieszka Anna Kuczaj, Szymon Warwas, Tomasz Hrapkowicz, Piotr Przybyłowski, Marta Tanasiewicz

Clinical Perspectives of Gut Microbiota in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: Where Do We Stand?

Alexandru Cosmin Pantazi, Mustafa Ali Kassim Kassim, Wassan Nori, Liliana Ana Tuta, Cristina Maria Mihai, Tatiana Chisnoiu, Adriana Luminita Balasa, Larisia Mihai, Ancuta Lupu, Corina Elena Frecus, Vasile Valeriu Lupu, Sergiu Ioachim Chirila, Anca Gabriel

Microbial-Derived Uremic Toxins: Role in the Pathogenesis of Comorbidities in Patients with Chronic Kidney Disease

M. O. Pyatchenkov, A. A. Vlasov, E. V. Sherbakov, S. P. Salikova

Russian Journal of Gastroenterology, Hepatology, Coloproctology.2023; 33(3): 7. CrossRef

Mario Caldarelli, Laura Franza, Pierluigi Rio, Antonio Gasbarrini, Giovanni Gambassi, Rossella Cianci

Planting a path to kidney health: The vegetarian diet and diabetic nephropathy

Impact of gut microbiota on kidney transplantation

Poramed Winichakoon, Romanee Chaiwarith, Nipon Chattipakorn, Siriporn C. Chattipakorn

Transplantation Reviews.2022; 36(1): 100668. CrossRef

Structural and functional intestinal barrier abnormalities and chronic kidney disease. Literature review. Part I

Nephrology (Saint-Petersburg).2022; 26(1): 10. CrossRef

The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial

Zarina Ebrahim, Sebastian Proost, Raul Yhossef Tito, Jeroen Raes, Griet Glorieux, Mohammed Rafique Moosa, Renée Blaauw

Microbiome in Chronic Kidney Disease (CKD): An Omics Perspective

The Role of Dietary Fiber and Gut Microbiome Modulation in Progression of Chronic Kidney Disease

Emotional and cognitive changes in chronic kidney disease

The Korean Journal of Internal Medicine.2022; 37(3): 489. CrossRef

Role of T cells in ischemic acute kidney injury and repair

The Korean Journal of Internal Medicine.2022; 37(3): 534. CrossRef

Dextran Sulphate Sodium Acute Colitis Rat Model: A Suitable Tool for Advancing Our Understanding of Immune and Microbial Mechanisms in the Pathogenesis of Inflammatory Bowel Disease

Petra Adamkova, Petra Hradicka, Helena Kupcova Skalnikova, Veronika Cizkova, Petr Vodicka, Silvia Farkasova Iannaccone, Monika Kassayova, Sona Gancarcikova, Vlasta Demeckova

The relationships among gut microbiota, hypoxia‐inducible factor and anaemia with chronic kidney disease

STRUCTURAL AND FUNCTIONAL INTESTINAL BARRIER ABNORMALITIES AND CHRONIC KIDNEY DISEASE. LITERATURE REVIEW. PART II

M. O. Pyatchenkov, A. S. Rumyantsev, E. V. Sherbakov, A. G. Markov

Nephrology (Saint-Petersburg).2022; 26(2): 46. CrossRef

POTENTIAL THERAPEUTIC OPTIONS TARGETING THE GUT DYSBIOSIS IN CHRONIC KIDNEY DISEASE

Wiadomości Lekarskie.2022; 75(7): 1757. CrossRef

Possible protective role of probiotic and symbiotic to limit the progression of chronic kidney disease in 5/6th nephrectomized albino rats

Bataa M. El-Kafoury, Nermine K. Saleh, M. K. Shawky, Nayra Mehanna, Elsayed Ghonamy, Dalia A. Saad

Bulletin of the National Research Centre.2022;[Epub] CrossRef

Indole and p-cresol in feces of healthy subjects: Concentration, kinetics, and correlation with microbiome

Francesco Candeliere, Marta Simone, Alan Leonardi, Maddalena Rossi, Alberto Amaretti, Stefano Raimondi

Frontiers in Molecular Medicine.2022;[Epub] CrossRef

Single Donor FMT Reverses Microbial/Immune Dysbiosis and Induces Clinical Remission in a Rat Model of Acute Colitis

Petra Adamkova, Petra Hradicka, Sona Gancarcikova, Monika Kassayova, Lubos Ambro, Izabela Bertkova, Martin Maronek, Silvia Farkasova Iannaccone, Vlasta Demeckova

How important is dietary management in chronic kidney disease progression? A role for low protein diets

The Korean Journal of Internal Medicine.2021; 36(4): 795. CrossRef

Lipid Disorders in NAFLD and Chronic Kidney Disease

Association between gut dysbiosis and chronic kidney disease: a narrative review of the literature

Zhe Feng, Ting Wang, Sheng Dong, Hongli Jiang, Jianzhong Zhang, Hafiz Khuram Raza, Genping Lei

Journal of International Medical Research.2021;[Epub] CrossRef